Softhale

Logo path
/content/dam/pmequitypartner/portfolio-products/softhale.png
Title
Novel Inhalation Technology
Description

Softhale is developing pharmaceutical inhalation products for major respiratory markets in the U.S., Europe, and Asia. These products are based upon a differentiated inhalation delivery technology called SOFTHALER®. This device is a next-generation Soft Mist Inhaler (SMI), which offers a platform technology for delivering various drugs to the lungs. As well as generic products, innovative products are also targeted.

PM Equity Partner has exited its investment in Softhale.

Website url
https://www.softhale.com/